Clinical Trials Browser

Enrolling by invitation × Interventional × Urinary Bladder Neoplasms × Clear all

Urinary Bladder Neoplasms

NCT07218003 2026-03-23

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

BreastGastrointestinalGenitourinaryGynecologicThoracic

Esophageal Squamous Cell Carcinoma, Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

NCT06243510 2026-01-28

CARE

Phase NA Enrolling by invitation

90 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07148765 2025-09-26

Use of Wearables Following Cystectomy- Part II

Phase NA Enrolling by invitation

50 enrolled

Genitourinary

Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic

NCT05739071 2025-09-11

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

Phase NA Enrolling by invitation

100 enrolled

Genitourinary

Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT06944314 2025-04-27

Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia

Phase NA Enrolling by invitation

120 enrolled

Genitourinary

Anxiety Disorders, Urinary Bladder Neoplasms, Hematuria, Pain

NCT06780358 2025-01-17

RAISE02

Phase NA Enrolling by invitation

64 enrolled

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

VIABLE

A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4

CARE

Use of Wearables Following Cystectomy- Part II

JING SI HERBAL TEA and Urinary Tract Symptoms in Bladder Cancer

Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia

RAISE02